Passport Capital’s Biogen BIIB Stock Holding History

Passport Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,671	Closed	-$1.55M	–	31
2017 Q1	$1.55M	Sell	5,671 -233	-4%	-$65.9K	0.11%	58
2016 Q4	$1.67M	Buy	+5,904	New	+$1.75M	0.03%	80
2015 Q4	–	Sell	-10,551	Closed	-$3.08M	–	119
2015 Q3	$3.08M	Buy	+10,551	New	+$3.48M	0.06%	81
2015 Q2	–	Sell	-46,268	Closed	-$19.5M	–	212
2015 Q1	$19.5M	Buy	+46,268	New	+$18.2M	0.51%	47
2014 Q2	–	Sell	-783	Closed	-$239K	–	199
2014 Q1	$239K	Buy	+783	New	+$249K	0.01%	140

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Passport Capital's BIIB Position: Q2 2017 in Review

Passport Capital sold out of Biogen (BIIB) in Q2 2017, closing a stake of 5,671 shares — an estimated $1.55M sold.

Passport Capital first reported a position in BIIB in Q1 2014 and held it in 5 quarters. The position peaked at $19.5M in Q1 2015. 993 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

Passport Capital reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
Passport Capital sold 5,671 Biogen shares in Q2 2017, an estimated $1.55M.
Passport Capital first reported a position in Biogen in Q1 2014 and held it in 5 quarters.
Passport Capital's Biogen position peaked at $19.5M in Q1 2015.
993 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Passport Capital's 13F filing for Q2 2017, filed 14 Aug 2017.